Rankings
▼
Calendar
RMD
ResMed Inc.
$35B
Q4 2020 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$770M
+9.3% YoY
Gross Profit
$449M
58.3% margin
Operating Income
$223M
29.0% margin
Net Income
$178M
23.1% margin
EPS (Diluted)
$1.22
QoQ Revenue Growth
+0.1%
Cash Flow
Operating Cash Flow
$330M
Free Cash Flow
$309M
Stock-Based Comp.
$16M
Balance Sheet
Total Assets
$4.6B
Total Liabilities
$2.1B
Stockholders' Equity
$2.5B
Cash & Equivalents
$463M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$770M
$705M
+9.3%
Gross Profit
$449M
$418M
+7.5%
Operating Income
$223M
$121M
+84.4%
Net Income
$178M
$69M
+158.5%
Revenue Segments
Devices And Masks
$679M
88%
Software As Service
$91M
12%
← FY 2020
All Quarters
Q1 2021 →
RMD Q4 2020 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena